Learn More
Medchemexpress LLC BR-cpd7 | 98.0% | 928.82 | 1 MG

Supplier: Medchemexpress LLC HY1637051MG
BR-cpd7 is a PROTAC degrader designed for fibroblast growth factor receptor FGFR1/2, exhibiting a DC50 of 10 nM. This compound has been observed to arrest the cell cycle and inhibit the proliferation of tumor cells that are aberrantly activated by FGFR1/2.
- Composed of a ligand for target protein FGFR-IN-12, a linker, and a ligand for E3 ligase Thalidomide-NH-CH2-COOH.
- Exhibits antitumor activity.
- Arrests cell cycle.
- Inhibits proliferation of FGFR1/2 aberrant activated tumor cells.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.